Description of antibiotic therapy of hospitalized-community-acquired pneumonia in PKU Muhammadiyah Gamping hospital
DOI:
https://doi.org/10.12928/pharmaciana.v12i1.17034Keywords:
Community pneumonia, intravenous antibiotics, comorbidities, intravenously, oral antibioticsAbstract
Long-term administration of IV antibiotics risks increasing treatment costs and patient morbidity, but until now, intravenous (IV) antibiotics are still the most comprehensive choice in treating community pneumonia inpatients in hospitals. The purpose of this study was to describe the use of antibiotics and duration of AB replacement from IV administration to oral administration (P.O) in community-acquired pneumonia (CAP) patients at PKU Muhammadiyah Gamping Hospital (PMGH). This study used a cross-sectional design. Data were collected prospectively by purposive sampling. Inclusion criteria were hospitalized patients with CAP who received AB IV therapy for 24-72 hours. Patients with lung cancer or sepsis were excluded. Data were collected from medical records, laboratory examination records, and drug administration. Data were analyzed univariately. The number of 38 patients according to the criteria with a mean age of 59.8 ± 12.7 years; most were male (55.3%) and comorbid with heart failure (13.2%). The mean length of hospitalization was 4.9 ± 1.6 days. Most of the patients received Cephalosporins antibiotic group, either given IV (89.5%) or P.O. (78.1%); the rest received the quinolone group. The mean time of changing AB from IV to oral administration was 134.25 ± 15.98 hours. Most inpatient CAP patients at PMGH received a cephalosporins group, either IV or orally.
References
Ahn, H. I., & Hyun, M. K. (2019). Effectiveness of integrative medicine program for dementia prevention on cognitive function and depression of elderly in a public health center. Integrative Medicine Research, 8(2), 133-137. https://doi.org/10.1016/j.imr.2019.04.008
Alotair, H. A., Hussein, M. A., Elhoseny, M. A., Alzeer, A. H., & Khan, M. F. (2015). Severe pneumonia requiring ICU admission: Revisited. Journal of Taibah University Medical Sciences, 10(3), 293-299. https://doi.org/10.1016/j.jtumed.2015.03.005
Bestari, M. P., & Karuniawati, H. (2019). Evaluasi rasionalitas dan efektifitas penggunaan antibiotik pada pasien pneumonia pediatrik di instalasi rawat inap Rumah Sakit pusat Jawa Tengah. Pharmacon: Jurnal Farmasi Indonesia, 14(2), 62-71. https://doi.org/10.23917/pharmacon.v14i2.6524
Cavallazzi, R., Wiemken, T., Arnold, F. W., Luna, C. M., Bordon, J., Kelley, R., Feldman, C., Chalmers, J. D., Torres, A., & Ramirez, J. (2015). Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit. Respiratory Medicine, 109(6), 743-750. https://doi.org/10.1016/j.rmed.2015.04.007
Chang, K. S., Tsai, W. H., Tsai, C. H., Yeh, H. I., Chiu, P. H., Chang, Y. W., Chen, H. Y., Tsai, J. M., & Lee, S. C. (2017). Effects of health education programs for the elders in community care centers – evaluated by health promotion behaviors. International Journal of Gerontology, 11(2), 109-113.
https://doi.org/10.1016/j.ijge.2017.03.009
Chastre, J., Blasi, F., Masterton, R. G., Rello, J., Torres, A., & Welte, T. (2014). European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical Microbiology and Infection, 20(S4), 19-36. https://doi.org/10.1111/1469-0691.12450
Cunha, B. A. (2001). Pneumonia in the elderly. Clinical Microbiology Infection, 7(3), 581-588. https://doi.org/10.1097/MCP.0b013e328326f571
Dimopoulos, G., Matthaiou, D. K., Karageorgopoulos, D. E., Grammatikos, A. P., Athanassa, Z., & Falagas, M. E. (2008). Short- versus long-course antibacterial therapy for community-acquired Pneumonia. 68(13), 1841-1854. https://doi.org/10.2165/00003495-200868130-00004
Dunkler, D., Kohl, M., Teo, K. K., Heinze, G., Dehghan, M., Clase, C. M., Gao, P., Yusuf, S., Mann, J. F. E., & Oberbauer, R. (2016). Population-attributable fractions of modifiable lifestyle factors for CKD and mortality in individuals with type 2 Diabetes: A Cohort Study. American Journal of Kidney Diseases, 68(1), 29-40. https://doi.org/10.1053/j.ajkd.2015.12.019
Eurich, D. T., Marrie, T. J., Minhas-Sandhu, J. K., & Majumdar, S. R. (2017). Risk of heart failure after community acquired pneumonia: Prospective controlled study with 10 years of follow-up. BMJ (Online), 356(February), 1-9. https://doi.org/10.1136/bmj.j413
Farida, Y., Trisna, A., & Nur, D. (2017). Study of antibiotic use on pneumonia patient in Surakarta referral hospital. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2(01), 44. https://doi.org/10.20961/jpscr.v2i01.5240
Ghazipura, M. (2013). Shorter Versus Longer Duration of Antibiotic Therapy in Patients With Community-Acquired Pneumonia: A Rapid Review. https://www.bing.com/search?q=Ghazipura%2C+M.+(2013).+Shorter+Versus+Longer+Duration+of+Antibiotic+Therapy+in+Patients+With+Community-Acquired+Pneumonia+%3A+A+Rapid+Review.+(November)%2C+1–20.&cvid=6da4443894e14316bb00f616fb71eb79&aqs=edge..69i57.1153j0j1&pglt=43&FORM=ANSPA1&PC=EDGEDB
Horowitz, R. I., Freeman, P. R., & Bruzzese, J. (2020). Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases. Respiratory Medicine Case Reports, 30, 101063. https://doi.org/10.1016/j.rmcr.2020.101063
Huang, S. T., Lin, C. L., Chang, Y. J., Sher, Y. P., Wu, M. J., Shu, K. H., Sung, F. C., & Kao, C. H. (2014). Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients. Kidney International, 86(5), 1023-1030. https://doi.org/10.1038/ki.2014.79
Machlaurin, A. (2015). Dampak pergantian terapi antibiotik intravena ke rute per oral terhadap analisis farmakoekonomi pasien Pneumonia selama rawat inap. Universitas Negeri Jakarta.
Machlaurin, A., Satibi, S., & Yasin, N. M. (2017). Penambahan Ciprofloksacin Intravena terhadap Ceftriakson sebagai Terapi Antibiotik Empiris pada Pasien Pneumonia Rawat Inap: Perbandingan Biaya dan Efektivitas. Buletin Penelitian Kesehatan, 45(2), 73-80. https://doi.org/10.22435/bpk.v45i2.6392.73-80
McKinnell, J. A., Corman, S., Patel, D., Leung, G. H., Gordon, L. M., & Lodise, T. P. (2018). Effective antimicrobial stewardship strategies for cost-effective utilization of telavancin for the treatment of patients with hospital-acquired bacterial pneumonia caused by Staphylococcus aureus. Clinical Therapeutics, 40(3), 406-414.e2. https://doi.org/10.1016/j.clinthera.2018.01.010
Mulyana, R. (2019). Terapi Antibiotika pada Pneumonia Usia Lanjut. Jurnal Kesehatan Andalas, 8(1), 172. https://doi.org/10.25077/jka.v8i1.987
Othman, H. A., Gamil, N. M., Elgazzar, A. E. M., & Fouad, T. A. (2017). Ventilator associated pneumonia, incidence and risk factors in emergency intensive care unit Zagazig university hospitals. Egyptian Journal of Chest Diseases and Tuberculosis, 66(4), 703-708. https://doi.org/10.1016/j.ejcdt.2017.08.004
Park, H. K., Song, J. U., Um, S. W., Koh, W. J., Suh, G. Y., Chung, M. P., Kim, H., Kwon, O. J., & Jeon, K. (2010). Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respiratory Medicine, 104(11), 1729-1735. https://doi.org/10.1016/j.rmed.2010.06.009
Prakoso, D., Posangi, J., & Nangoy, E. (2018). Gambaran dan Rasionalitas Penggunaan Antibiotik pada Pasien Dewasa dengan Community Acquired Pneumonia di RSUP Prof. Dr. R. D. Kandou Manado Periode Juni 2017-Mei 2018. Jurnal E-Biomedik, 6(2), 166-173. https://doi.org/10.35790/ebm.6.2.2018.22156
Putri, R. M., & Hasan, H. (2014). Tinjauan imunologi pneumonia pada pasien geriatri. Cermin Dunia Kedokteran, 14(1), 14-18
Ramirez, J. A., Cooper, A. C., Wiemken, T., Gardiner, D., & Babinchak, T. (2012). Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin. BMC Infectious Diseases, 12(1), 1. https://doi.org/10.1186/1471-2334-12-159
Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., Adebiyi, A. O., Al-Aly, Z., Aleman, A. V., Ali, R., Alkerwi, A. Al, Allebeck, P., Al-Raddadi, R. M., Amare, A. T., Amberbir, A., - Gakidou, E. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: A systematic analysis from the global burden of disease study 2015. The Lancet, 389(10082), 1885-1906. https://doi.org/10.1016/S0140-6736(17)30819-X
Rusmini. (2016). Gambaran Penggunaan Antibiotik Pada Pasien Pneumonia Dengan Menggunakan Metode Gyssens Di Rawat Inap Rumah Sakit Umum Daerah (RSUD) H. Abdul Moeloek Tahun 2015. Jurnal Medika Malahayati, 3(2), 61-64. http://ejurnalmalahayati.ac.id/index.php/medika/article/view/2009/1267
Sari, E. F., Rumende, C. M., & Harimurti, K. (2017). Faktor-faktor yang berhubungan dengan diagnosis pneumonia pada pasien usia lanjut. Jurnal Penyakit Dalam Indonesia, 3(4), 183. https://doi.org/10.7454/jpdi.v3i4.51
Sari, I. P., Nuryastuti, T., Asdie, R. H., Pratama, A., & Estriningsih, E. (2017). Perbandingan pola terapi antibiotik pada Community- Acquired Pneumonia (CAP) di Rumah Sakit Tipe A dan B. Jurnal Manajemen Dan Pelayanan Farmasi, 7(4), 168-174
Seok, H., Ko, J.-H., Peck, K. R., Kim, J.-Y., Lee, J. H., Park, G. E., Cho, S. Y., Kang, C.-I., Lee, N. Y., & Chung, D. R. (2019). Treatment of Community-onset Pneumonia in Neutropenic Cancer Patients. Pneumonia, 11(1), 1-7
Shrayteh, Z. M., Rahal, M. K., & Malaeb, D. N. (2014). Practice of switch from intravenous to oral antibiotics. SpringerPlus 3, 3(717), 3-8
Suharjono, T, Y., Sumarno, & S.J, S. (2009). Studi Penggunaan Antibiotika Pada Penderita Rawat Inap Pneumonia (Penelitian Di Sub Departemen Anak Rumkital Dr. Ramelan Surabaya). Pharmaceutical Sciences and Research, 6(3). https://doi.org/10.7454/psr.v6i3.3443
Tambun, S. H., Puspitasari, I., & Laksanawati, I. S. (2019). Evaluasi luaran klinis terapi antibiotik pada pasien community acquired pneumonia anak rawat inap. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 9(3), 213. https://doi.org/10.22146/jmpf.47915
Teixeira-Lopes, F., Cysneiros, A., Dias, A., Durão, V., Costa, C., Paula, F., Serrado, M., Nunes, B., Diniz, A., & Froes, F. (2019). Intra-hospital mortality for community-acquired pneumonia in mainland Portugal between 2000 and 2009. Pulmonology, 25(2), 66-70. https://doi.org/10.1016/j.pulmoe.2018.06.004
Tejaswini, Y. S., Challa, S. R., Nalla, K. S., Gadde, R. S., Pavani, A. L. H., & Neerisha, V. (2018). Practice of intravenous to oral conversion of antibiotics and its influence on length of stay at a tertiary care hospital: A prospective study. Journal of Clinical and Diagnostic Research, 12(3), FC0-FC04. https://doi.org/10.7860/JCDR/2018/31647.11246
Vila-Corcoles, A., Ochoa-Gondar, O., Rodriguez-Blanco, T., Raga-Luria, X., & Gomez-Bertomeu, F. (2009). Epidemiology of community-acquired pneumonia in older adults: A population-based study. Respiratory Medicine, 103(2), 309-316. https://doi.org/10.1016/j.rmed.2008.08.006
Von Lilienfeld-Toal, M., Berger, A., Christopeit, M., Hentrich, M., Heussel, C. P., Kalkreuth, J., Klein, M., Kochanek, M., Penack, O., Hauf, E., Rieger, C., Silling, G., Vehreschild, M., Weber, T., Wolf, H. H., Lehners, N., Schalk, E., & Mayer, K. (2016). Community acquired respiratory virus infections in cancer patients' Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. European Journal of Cancer, 67, 200-212. https://doi.org/10.1016/j.ejca.2016.08.015
Ziółkowski, G., Pawłowska, I., Krawczyk, L., & Wojkowska-Mach, J. (2018). Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014–2015. Journal of Infection and Public Health, 11(5), 626–630. https://doi.org/10.1016/j.jiph.2018.02.003
Downloads
Published
Issue
Section
License
Authors who publish with Pharmaciana agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
1.png)
